Manhattan West Asset Management LLC Cuts Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Manhattan West Asset Management LLC decreased its position in HCA Healthcare, Inc. (NYSE:HCA) by 22.2% in the first quarter, Holdings Channel reports. The institutional investor owned 660 shares of the company’s stock after selling 188 shares during the period. Manhattan West Asset Management LLC’s holdings in HCA Healthcare were worth $220,000 as of its most recent filing with the SEC.

Several other hedge funds have also modified their holdings of HCA. Atlantic Edge Private Wealth Management LLC acquired a new stake in HCA Healthcare in the fourth quarter valued at approximately $27,000. LifeSteps Financial Inc. purchased a new stake in HCA Healthcare in the 1st quarter worth $33,000. Rise Advisors LLC purchased a new position in HCA Healthcare during the first quarter valued at $36,000. Northwest Investment Counselors LLC acquired a new position in shares of HCA Healthcare during the 1st quarter worth about $36,000. Finally, Activest Wealth Management purchased a new stake in HCA Healthcare during the 1st quarter worth approximately $40,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Trading Up 0.6 %

Shares of NYSE:HCA traded up $1.99 during mid-day trading on Friday, reaching $354.78. 1,215,941 shares of the company were exchanged, compared to its average volume of 1,679,664. HCA Healthcare, Inc. has a 1 year low of $215.96 and a 1 year high of $356.30. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 1.02. The firm’s 50-day simple moving average is $330.12 and its 200 day simple moving average is $323.11. The firm has a market cap of $92.92 billion, a price-to-earnings ratio of 17.69, a P/E/G ratio of 1.35 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the company posted $4.29 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 22.43 EPS for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 0.74%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Analysts Set New Price Targets

Several brokerages recently commented on HCA. Cantor Fitzgerald reiterated an “overweight” rating and set a $335.00 price target on shares of HCA Healthcare in a research report on Wednesday. SVB Leerink raised their price target on shares of HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a research note on Wednesday. StockNews.com upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Truist Financial upped their price target on HCA Healthcare from $375.00 to $390.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, Deutsche Bank Aktiengesellschaft upped their target price on HCA Healthcare from $359.00 to $375.00 and gave the company a “buy” rating in a report on Friday, June 28th. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $339.72.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 6,311 shares of HCA Healthcare stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $316.88, for a total transaction of $1,999,829.68. Following the completion of the sale, the executive vice president now directly owns 29,624 shares of the company’s stock, valued at approximately $9,387,253.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other HCA Healthcare news, EVP Michael S. Cuffe sold 6,311 shares of HCA Healthcare stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $316.88, for a total value of $1,999,829.68. Following the sale, the executive vice president now owns 29,624 shares of the company’s stock, valued at approximately $9,387,253.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Jeffrey E. Cohen sold 1,650 shares of the business’s stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $313.00, for a total value of $516,450.00. Following the sale, the senior vice president now directly owns 5,185 shares in the company, valued at approximately $1,622,905. The disclosure for this sale can be found here. In the last three months, insiders sold 12,397 shares of company stock valued at $3,921,929. Insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.